Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement
Jérôme Boursier, Rodolphe Anty, Claire Carette, et al.
Diabetes & Metabolism (2021) Vol. 47, Iss. 5, pp. 101272-101272
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

A global view of the interplay between non-alcoholic fatty liver disease and diabetes
Norbert Stefan, Kenneth Cusi
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 4, pp. 284-296
Closed Access | Times Cited: 402
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
Wah‐Kheong Chan, Kee Huat Chuah, Ruveena Bhavani Rajaram, et al.
Journal of Obesity & Metabolic Syndrome (2023) Vol. 32, Iss. 3, pp. 197-213
Open Access | Times Cited: 281
Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction–associated steatotic liver disease
Xiaolong Qi, Jie Li, Cyrielle Caussy, et al.
Hepatology (2024)
Open Access | Times Cited: 19
Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications
Jérôme Boursier, Clémence M. Canivet, Charlotte Costentin, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 21, Iss. 5, pp. 1243-1251.e12
Closed Access | Times Cited: 61
Diabetes and cirrhosis: Current concepts on diagnosis and management
Laurent Castéra, Kenneth Cusi
Hepatology (2023) Vol. 77, Iss. 6, pp. 2128-2146
Closed Access | Times Cited: 38
From liver to hormones: The endocrine consequences of cirrhosis
Juan Eduardo Quiroz‐Aldave, Elman Rolando Gamarra‐Osorio, María del Carmen Durand‐Vásquez, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 9, pp. 1073-1095
Open Access | Times Cited: 8
Anti-hepatopathy and anti-nephropathy activities of Taraxacum officinale in a rat model of Streptozotocin diabetes-induced hepatorenal toxicity and dyslipidemia via attenuation of oxidative stress, inflammation, apoptosis, electrolyte imbalances, and mitochondrial dysfunction
Sunday Aderemi Adelakun, Aniah Julius Akomaye, O Omotoso, et al.
Aspects of Molecular Medicine (2024) Vol. 3, pp. 100034-100034
Open Access | Times Cited: 6
Clinical implications of diabetes in chronic liver disease: Diagnosis, outcomes and management, current and future perspectives
Diego García‐Compeán, Emanuela Orsi, Ramesh Kumar, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 8, pp. 775-793
Open Access | Times Cited: 26
Current challenges and future perspectives in treating patients with NAFLD-related cirrhosis
Maxime Mallet, Cristina Alina Silaghi, Philippe Sultanik, et al.
Hepatology (2023) Vol. 80, Iss. 5, pp. 1270-1290
Closed Access | Times Cited: 14
Liver and cardiovascular disease outcomes in metabolic syndrome and diabetic populations: Bi-directional opportunities to multiply preventive strategies
Alhussain Yasin, Madison Nguyen, Angad Sidhu, et al.
Diabetes Research and Clinical Practice (2024) Vol. 211, pp. 111650-111650
Closed Access | Times Cited: 5
Therapeutic Physical Exercise Programs in the Context of NASH Cirrhosis and Liver Transplantation: A Systematic Review
Marwin A. Farrugia, Sébastien Le Garf, Andréa Chierici, et al.
Metabolites (2023) Vol. 13, Iss. 3, pp. 330-330
Open Access | Times Cited: 10
Innovative Drugs First Implemented in Type 2 Diabetes Mellitus and Obesity and Their Effects on Metabolic Dysfunction-Associated Steatohepatitis (MASH)-Related Fibrosis and Cirrhosis
Georgiana-Diana Cazac, C.M. Lǎcǎtusu, Elena-Daniela Grigorescu, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1042-1042
Open Access
Association of alkaline phosphatase to albumin ratio with all-cause mortality in critically ill patients with cirrhosis: a retrospective study
Hongye Peng, Tao Zheng, Na Zeng, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Management of type 2 diabetes in patients with compensated liver cirrhosis: Short of evidence, plenty of potential
Konstantinos Arvanitakis, Theocharis Koufakis, Georgios Kalopitas, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2023) Vol. 18, Iss. 1, pp. 102935-102935
Closed Access | Times Cited: 9
Influence of ursodeoxycholic acid on blood glucose, insulin and GLP-1 in rats with liver fibrosis induced by bile duct ligation
Bai Xiu-ping, Wenjin Du, Hua-Bing Xing, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Acute-on-chronic liver failure in metabolic dysfunction-associated fatty liver disease patients: a disease multiplier
Ashok Choudhury, Ruveena Bhavani Rajaram, Shiv Kumar Sarin
Hepatology International (2024) Vol. 18, Iss. S2, pp. 941-958
Closed Access | Times Cited: 2
Poor glycemic control in type‐2 diabetic patients infected with hepatitis B: A retrospective propensity‐matched study
Ting Cai, Tingting Yue, Ming Xu, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Closed Access | Times Cited: 5
Serum 25-hydroxyvitamin D, type 2 diabetes, and liver-related outcomes: Secondary data analysis of a prospective recruited cohort
Yu Wang, Lintao Dan, Tian Fu, et al.
Hepatology Communications (2023) Vol. 7, Iss. 11
Open Access | Times Cited: 5
The Impact of Metabolic Health and Obesity on Liver Transplant Candidates and Recipients
Alexander S. Vogel, Rebecca Roediger, Dagny Von Ahrens, et al.
Life (2024) Vol. 14, Iss. 6, pp. 685-685
Open Access | Times Cited: 1
Impact of peptic ulcer bleeding on the in-hospital outcomes of cirrhotic patients with acute gastrointestinal bleeding: an international multicenter study
Yuhang Yin, Fanpu Ji, Fernando Gomes Romeiro, et al.
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 8, pp. 473-483
Closed Access | Times Cited: 1
Comparative effects between old and new antidiabetic agents on metabolic- associated fatty liver disease (MAFLD)
André Scheen
Diabetes Epidemiology and Management (2023) Vol. 11, pp. 100145-100145
Open Access | Times Cited: 3
Dual metformin and glucagon-like peptide-1 receptor agonist therapy reduces mortality and hepatic complications in cirrhotic patients with diabetes mellitus
Daniel J. Huynh
Annals of Gastroenterology (2023)
Open Access | Times Cited: 3
Pharmacokinetic, toxicological, and clinical considerations for the treatment of type 2 diabetes in patients with liver disease: a comprehensive update
André Scheen
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 8, pp. 543-553
Closed Access | Times Cited: 3
HCV Infection and Liver Cirrhosis Are Associated with a Less-Favorable Serum Cholesteryl Ester Profile Which Improves through the Successful Treatment of HCV
Kilian Weigand, Georg Peschel, Jonathan Grimm, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3152-3152
Open Access | Times Cited: 5
Oleic Acid and Succinic Acid: A Potent Nutritional Supplement in Improving Hepatic Glycaemic Control in Type 2 Diabetic Sprague–Dawley Rats
Kemmoy Lattibeaudiere, Ruby Alexander-Lindo
Advances in Pharmacological and Pharmaceutical Sciences (2024) Vol. 2024, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top